# Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients

> **NCT00553930** · PHASE4 · COMPLETED · sponsor: **Sociedad Andaluza de Enfermedades Infecciosas** · enrollment: 71 (estimated)

## Conditions studied

- Hepatitis C, Chronic
- HIV Infections

## Interventions

- **DRUG:** Pegylated interferon alfa-2a and Ribavirin
- **DRUG:** Pegylated interferon alfa 2a and Ribavirin

## Key facts

- **NCT ID:** NCT00553930
- **Lead sponsor:** Sociedad Andaluza de Enfermedades Infecciosas
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 71 (ESTIMATED)
- **Last updated:** 2010-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00553930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00553930, "Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00553930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*